A novel bioanalytical method for the quantification of pemigatinib in rat plasma by UPLC-MS/MS

Weng, QH; Tan, W; Yu, RY; Xu, RA; Chen, Y

Xu, RA; Chen, Y (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Nanbaixiang St, Wenzhou 325000, Peoples R China.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021; 202 ():

Abstract

Pemigatinib is an oral, selective, potent, competitive inhibitor acting on fibroblast growth factor receptor (FGFR)1, FGFR2, and FGFR3, which has obta......

Full Text Link